PhD Programme Epidemiology

People sitting at computers in a seminar room

The PhD programme “Epidemiology” is a three-year doctoral programme in the area of epidemiological research and is coordinated by the Department of Epidemiology of the HZI.

The PhD programme is a collaborative effort of the Department of Epidemiology, the HZI Grad School and the HBRS (MHH). After successful completion, candidates will be awarded a PhD or, in some instances, a Dr. rer. nat.

Current admissions for the PhD Programme are only possible if funding is assured by the applicant (e.g. by a scholarship or a third party).

During the course of the programme, PhD fellows are being prepared to conduct independent epidemiological and public health relevant research. After successful completion, the fellows can enter career paths in academia, research and science, national health institutions, ministries, health insurances, international organizations or other non-governmental organizations.

The programme supports individual training and career plans according to background studies and interests.

Further objectives of the programme include:

  • To gather experience in independent planning, management, implementation, and evaluation of epidemiological research projects
  • To acquire comprehensive knowledge on epidemiological and statistical methods
  • To scientifically contribute to narrow evidence gaps in epidemiological and health research
  • To acquire the ability to present results and methods of epidemiological research at conferences and in peer-reviewed journals 
  • To  support the understanding of Good Epidemiological Practice
Programme and Research
Curriculum PhD Epidemiology
Exemplary structure of the PhD programme "Epidemiology"
  • The duration of each PhD programme cycle is three years.
  • The PhD programme is structured into individual epidemiological research activity on the one hand (125 Credit Points) and accompanying mandatory educational programme (55 Credit Points, minimum 300 Teaching Units (TU's)) on the other hand.
  • The accompanying educational programme contains lectures and seminars, as well as epidemiological fieldwork in our study centre and epidemiological laboratory.
  • All training elements are taught in English. The PhD programme is integrated in and supported by a network of PhD students, PostDocs and supervisors with various scientific backgrounds.

Very important: Declaration of consent for the application procedure

The Helmholtz Centre for Infection Research (HZI) takes the protection of personal data very seriously [according to the European General Data Protection Regulation (GDPR)]. 

If you wish to apply or already applied via email, please enclose the following declaration of consent with your application:

“I, ………………………, hereby consent to all personal data provided by me during the application procedure being processed by the HZI. I have read the HZI privacy policy and am informed about my rights."

Without this consent we cannot consider/pursue your application any further, all documents already sent will be deleted immediately.

Prerequisites for application:

  • Please attach the declaration of consent for the application procedure when contacting us for the first time (see note above).
  • University degree (master's degree or equivalent) in the area of medicine, dentistry, veterinary medicine, pharmacy, natural science, or in another subject area with a biomedical or health relevant focus. The degree must entitle the applicant to pursue a PhD studies in Germany (verification for this is carried out by an official authority)
  • Fluency in English, written and spoken
  • Knowledge and prior experience in the area of epidemiological methods and statistics equivalent to a degree like MSE, MSc Epidemiology, MPH, or MSAE.  In individual cases, where such formal degree is lacking, successfully passed courses in the field of statistics and epidemiology with 120 contact hours and/or 10 ETCS can also be acknowledged.
  • Submission of complete application documents (via e-mail), including a CV (listing academic degrees), a motivational letter, the bachelor and master certificates including corresponding transcripts (in original language and English translation)
  • Submission of a research proposal (template Application Exposé) that preferably addresses one of the listed research areas (link)
  • Funding: Financial framework that allows execution of the PhD project (e.g. by third party project funding)
  • Successful presentation of the project to the PhD Programme Commission.


  • Final decision on acceptance to the PhD Programme “Epidemiology” is taken by the PhD Programme Commission based on above mentioned prerequisites.
  • Admission will be followed by enrollment at the MHH at the earliest possible date (beginning of each semester).
  • There are no tuition fees. Please, check the website for the regular semester fee of the MHH, which includes the semester ticket for public transportation.


Al-Mekhlafi A, and Klawonn F (2023) HiPerMAb: a tool for judging the potential of small sample size biomarker pilot studies, Int. J. Biostat.

Fernández Villalobos NV, Kessel B, Torres Páez JC, Strömpl J, Kerrinnes T, de la Hoz Restrepo FP, Strengert M and Krause G. (2023) Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study, Front Public Health 11, 981172.

Kessel B, Heinsohn T, Ott JJ, Wolff J, Hassenstein MJ and Lange B (2023) Impact of Covid-19 Pandemic and Anti-Pandemic Measures on Tuberculosis, Viral Hepatitis, Hiv/Aids and Malaria-a Systematic Review." PLOS Glob Public Health 3, no. 5.

Lotto Batista M, Rees EM, Gomez A, Lopez S, Castell S, Kucharski AJ, Ghozzi S, Muller GV and Lowe R. (2023) Towards a leptospirosis early warning system in northeastern Argentina, J R Soc Interface 20, 20230069.



Fernández Villalobos NV, Kessel B, Rodiah I, Ott JJ, Lange B, Krause G (2022) Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis, PloS one 17: e0269253.

Coors A and Hassenstein MJ, Krause G, Kerrinnes T, Harries M, Breteler MMB and Castell S (2022) Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany, Parasit Vectors 15: 241.

Dulovic A, Kessel B, Harries M, Becker M, Ortmann J, Griesbaum J, Jüngling J, Junker D, Hernández P, Gornyk D et al. (2022) Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Front Immunol 13: 828053.

Jacobsen H,Strengert M, Maaß H, Ynga Durand MA, Kessel B, Harries M (…) Castell S, Gornyk D, Glöckner S,  Melhorn V, Kemmling Y, Lange B, et al. (2022) Diminished Neutralization Responses Towards Sars-Cov-2 Omicron Voc after Mrna or Vector-Based Covid-19 Vaccinations. medRxiv

Harries M, Jaeger VK, Rodiah I, Hassenstein MJ, Ortmann J, Dreier M, von Holt I, Brinkmann M, Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinki M, Schlotz, M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A and Lange B. (2022) Briding the gap – estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel, medRxiv, 2022.2012.2030.22284061.

Hassenstein MJ, Vanella, P (2022) Data Quality - Concepts and Problems, Encyclopedia 2, no. 1: 498-510.
DOI 10.3390/encyclopedia2010032

Hassenstein MJ, Janzen I., Krause G, Harries M, Melhorn V, Kerrinnes T, Kemmling Y and Castell S (2022) Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover, Microorganisms 10

Häring J, Hassenstein MJ, Becker M, Ortmann J, Junker D, Karch A, Berger K, Tchitchagua T, Leschnik O, Harries M, Gornyk D, Hernández P, Lange B, Castell S, Krause G, Dulovic A, Strengert M, and Schneiderhan-Marra N (2022) Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies, BMC Infectious Diseases 22, 859.

Kwabla MP, Klett-Tammen CJ, Castell S (2022) Barriers and motivation for presumptive tuberculosis case referral: qualitative analysis among operators of community medicine outlets in Ghana, BMC Health Serv Res 22: 980.

Akmatov MK, Holstiege J, Dammertz L, Heuer J, Kohring C, Lotto-Batista M, et al. Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019. Euro Surveill. 2022;27(32)

Rübsamen N, Garcia Voges B, Castell S, Klett-Tammen JC et al. (2022) Providing Laypeople with Results from Dynamic Infectious Disease Modelling Studies Affects Their Allocation Preference for Scarce Medical Resources—a Factorial Experiment. BMC Public Health 22, no. 1 (2022/03/23 2022): 572.

Silenou BC, Verset C, Kaburi BB, Leuci O, Ghozzi S, Duboudin C, Krause G (2022) A Novel Tool for Real-time Estimation of Epidemiological Parameters of Communicable Diseases Using Contact-Tracing Data: Development and Deployment. JMIR Public Health Surveill 8: e34438.

Umutesi J, Nsanzimana S, Yingkai Liu C, Vanella P, Ott JJ, Krause G (2022) Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting, BMC Infect Dis 22: 500.



Al-Mekhlafi A, Sühs K-W, Schuchardt S, Kuhn M, Müller-Vahl K, Trebst C, Skripuletz T, Klawonn F, Stangel M, Pessler F (2021) Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial from Viral CNS Infections. Cells 10: 1115.

Lambert JF, Stete K, Balmford J, Bockey A, Kern W, Rieg S, Boeker M, Lange B (2021) Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries, BMC Infect Dis 21: 872.

Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, Bockey A, Vanella P, Krause G, Lange B (2021) Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis, Systematic Reviews 10: 194.

Gornyk D, Scharlach M, Buhr-Riehm B, Klett-Tammen CJ, Eberhard S, Stahmeyer JT, Großhennig A, Smith A, Meinicke S, Bautsch W et al. (2021) Effectiveness of trainings of General Practitioners on antibiotic stewardship: A pragmatic quasi-experimental study in a controlled before-after design in South-East-Lower Saxony, Germany (WASA). Front Pharmacol 12: 533248.

Gornyk D, Harries M, Glöckner S, Strengert M, Kerrinnes T, Heise JK, et al. SARS-CoV-2 Seroprevalence in Germany. Dtsch Arztebl Int. 2021;118(48):824-31.

Kwabla MP, Amuasi JH, Krause G, Klett-Tammen C J, Castell S (2021) Referral of presumptive TB among operators of community medicine outlets, Int J Tuberc Lung Dis 25: 982-989.

Lotto Batista M, Behrens C, Castell S (2021) Der Einfluss des Klimawandels auf die Ausbreitung von Infektionserkrankungen – am Beispiel der Lyme-Borreliose. Buch: Versorgungs-Report: Klima und Gesundheit, 11, 145-155.

Nguyen MTH, Krause G, Keller-Stanislawski B, Glöckner S, Mentzer D, Ott JJ (2021) Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study. JMIR Mhealth Uhealth 9: e26289.

Silenou BC, Nyirenda, J. L. Z., Zaghloul, A., Lange, B., Doerrbecker, J., Schenkel, K, Krause G (2021) Availability and Suitability of Digital Health Tools in Africa for Pandemic Control: Scoping Review and Cluster Analysis, JMIR public health and surveillance 7: e30106-e30106.

Perrocheau A, Brindle H, Roberts C, Murthy S, Shetty S, Martin AIC, Marks M, Schenkel K, Silenou B, et al. (2021) Data collection for outbreak investigations: process for defining a minimal data set using a Delphi approach. BMC Public Health 21: 2269.

Umutesi J, Klett-Tammen C, Nsanzimana S, Krause G, Ott JJ (2021) Cross-sectional study of chronic hepatitis B virus infection in Rwandan high-risk groups: unexpected findings on prevalence and its determinants, BMJ open 11: e054039.



Al-Mekhlafi A, Becker T, Klawonn F (2020) Sample size and performance estimation for biomarker combinations based on pilot studies with small sample sizes. Communications in Statistics - Theory and Methods: 1-15.

Apenteng OO, Osei PP, Oduro B, Kwabla MP, Ismail NA (2020) The impact of implementing HIV prevention policies therapy and control strategy among HIV and AIDS incidence cases in Malaysia. Infectious Disease Modelling 5: 755-765.

Bockey AJ, Janda A, Braun C, Müller A-M, Stete K, Kern WV, Rieg SR, Lange B (2020) Patient satisfaction & use of health care: a cross-sectional study of asylum seekers in the Freiburg initial reception centre. BMC Health Services Research 20: 709.

Hassenstein MJ, Aarabi G, Ahnert P, Becher H, Franzke C-W, Fricke J, Krause G, Glöckner S, Gottschick C, Karch A, et al. (2020) Selbst berichtete Infektionen in der NAKO Gesundheitsstudie – Einordnung in die gegenwärtige Forschungslandschaft. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 63: 404-414.

Luo Y, Möhn N, Al-Mekhlafi A, Schuchardt S, Skripuletz T, Sühs W, Pessler F, Stangel M. (2020). Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy. PLoS One, 15(11), e0242321.

Nguyen MTH, Ott JJ, Caputo M, Keller-Stanislawski B, Klett-Tammen CJ, Linnig S, Mentzer D, Krause G (2020) User preferences for a mobile application to report adverse events following vaccination. Pharmazie 75: 27-31.

Silenou, B, Tom-Aba D, Adeoye O, Arinze C, Oyiri F, Suleman A, Yinka-Ogunleye A, Dörrbecker J, Ihekweazu C, Krause G (2020) Use of Surveillance Outbreak Response Management and Analysis System for Human Monkeypox Outbreak, Nigeria, 2017-2019. Emerging infectious diseases 26: 345-349.

Tom-Aba D, Silenou BC, Doerrbecker J, Fourie C, Leitner C, Wahnschaffe M, Strysewske M, Arinze CC, Krause G (2020) The Surveillance Outbreak Response Management and Analysis System (SORMAS): Digital Health Global Goods Maturity Assessment. JMIR public health and surveillance 6: e15860-e15860.



Caputo M, Horn J, Karch A, Akmatov MK, Becher H, Braun B, . . . Mikolajczyk R. (2019). Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort. BMC Infect Dis, 19(1), 99.

Caputo M, Stumpe V, Rubsamen N, Mikolajczyk RT, Karch A. (2019). Implementation of preventive measures against tick-borne infections in a non-endemic area for tick-borne encephalitis – Results from a population-based survey in Lower Saxony, Germany. Ticks Tick Borne Dis, 10(3), 614-620.

Caputo M, Zoch-Lesniak B, Karch A, Vital M, Meyer F, Klawonn F, . . . Mikolajczyk RT. (2019). Bacterial community structure and effects of picornavirus infection on the anterior nares microbiome in early childhood. BMC Microbiol, 19(1), 1.

Grylka-Baeschlin S, Clarke M, Begley C, Daly D, Healy P, Nicoletti J, . . . Gross MM. (2019). Labour characteristics of women achieving successful vaginal birth after caesarean section in three European countries. Midwifery, 74, 36-43.

Raupach-Rosin H, Rübsamen N, Schütte G, Raschpichler G, Chaw PS, Mikolajczyk R. (2019). Knowledge on Antibiotic Use, Self-Reported Adherence to Antibiotic Intake, and Knowledge on Multi-Drug Resistant Pathogens – Results of a Population-Based Survey in Lower Saxony, Germany. 10(776).

Silenou BC, Avalos M, Helmer C, Berr C, Pariente A, Jacqmin-Gadda H. (2019). Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data. PLoS One, 14(1), e0211118.

Zoch-Lesniak B, Ware RS, Grimwood K, Lambert SB. (2019). The Respiratory Specimen Collection Trial (ReSpeCT): A Randomized Controlled Trial to Compare Quality and Timeliness of Respiratory Sample Collection in the Home by Parents and Healthcare Workers From Children Aged <2 Years. J Pediatric Infect Dis Soc.



Akmatov MK, Rubsamen N, Deyneko IV, Karch A, Mikolajczyk RT. (2018). Poor knowledge of vaccination recommendations and negative attitudes towards vaccinations are independently associated with poor vaccination uptake among adults - Findings of a population-based panel study in Lower Saxony, Germany. Vaccine, 36(18), 2417-2426.

Chaw PS, Schlinkmann KM, Raupach-Rosin H, Karch A, Pletz MW, Huebner J, Nyan O, Mikolajczyk R. (2018). Antibiotic use on paediatric inpatients in a teaching hospital in the Gambia, a retrospective study. Antimicrob Resist Infect Control, 7, 82.

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, . . . Mikolajczyk RT. (2018). Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study. BMC Medicine, 16(1), 3.

Horn J, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk RT, Krause G, Ott JJ. (2018). Epidemiologic estimates of hepatitis E virus infection in European countries. J Infect, 77(6), 544-552.

Limaye D, Limaye V, Fortwengel G, Krause G. (2018). Self-medication practices in urban and rural areas of western India: a cross sectional study. International Journal of Community Medicine And Public Health, 5(7), 2672.

Obenauer J, Rübsamen N, Castell S, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk RT, Karch A. (2018). Perceptions of Zika virus risk in Germany in 2016. Eur J Public Health, 28(1), 139-144.

Obenauer J, Rübsamen N, Garsevanidze E, Karch A, Mikolajczyk RT. (2018). Changes in risk perceptions during the 2014 Ebola virus disease epidemic: results of two consecutive surveys among the general population in Lower Saxony, Germany. BMC Public Health, 18(1), 628.

Schlinkmann KM, Bakuli A, Karch A, Meyer F, Dreesman J, Monazahian M, Mikolajczyk R. (2018). Transmission of respiratory and gastrointestinal infections in German households with children attending child care. Epidemiology and Infection, 146(5), 627-632.

Tom-Aba D, Nguku PM, Arinze CC, Krause G. (2018). Assessing the Concepts and Designs of 58 Mobile Apps for the Management of the 2014-2015 West Africa Ebola Outbreak: Systematic Review. JMIR Public Health Surveill, 4(4), e68.

Tom-Aba D, Toikkanen SE, Glockner S, Adeoye O, Mall S, Fahnrich C, . . . Krause G. (2018). User Evaluation Indicates High Quality of the Surveillance Outbreak Response Management and Analysis System (SORMAS) After Field Deployment in Nigeria in 2015 and 2018. Stud Health Technol Inform, 253, 233-237.



Bakuli A, Klawonn F, Karch A, Mikolajczyk R. (2017). Effects of pathogen dependency in a multi-pathogen infectious disease system including population level heterogeneity - a simulation study. Theor Biol Med Model, 14(1), 26.

Chaw PS, Schlinkmann KM, Raupach-Rosin H, Karch A, Pletz MW, Huebner J, Mikolajczyk R. (2017). Knowledge, attitude and practice of Gambian health practitioners towards antibiotic prescribing and microbiological testing: a cross-sectional survey. Transactions of The Royal Society of Tropical Medicine and Hygiene, 111(3), 117-124.

Cuny C, Arnold P, Hermes J, Eckmanns T, Mehraj J, Schoenfelder S, . . . Witte W. (2017). Occurrence of cfr-mediated multiresistance in staphylococci from veal calves and pigs, from humans at the corresponding farms, and from veterinarians and their family members. Vet Microbiol, 200, 88-94.

Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, . . . Greiner W. (2017). Cost-effectiveness of human papillomavirus vaccination in Germany. Cost Effectiveness and Resource Allocation, 15(1), 18.

Karo B, Krause G, Castell S, Kollan C, Hamouda O, Haas W, ClinSurv HIVSG. (2017). Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. BMC Infect Dis, 17(1), 517.

Limaye D, Limaye V, Krause G, Fortwengel G. (2017). A systematic review of the literature on survey questionnaires to assess self-medication practices. International Journal of Community Medicine and Public Health, 2017(4(8)), 2620-2631.

Limaye D, Limaye V, Krause G, Fortwengel G. (2017). A Systematic Review of the Literature to Assess Self-medication Practices. Ann Med Health Sci Res, 7, 1-15.

Meyer F, Karch A, Schlinkmann KM, Dreesman J, Horn J, Rubsamen N, Sudradjat H, Schubert R, Mikolajczyk R. (2017). Sociodemographic determinants of spatial disparities in early childhood caries: An ecological analysis in Braunschweig, Germany. Community Dent Oral Epidemiol, 45(5), 442-448.

Nguyen VK, Hernandez-Vargas EA. (2017). Windows of opportunity for Ebola virus infection treatment and vaccination. Sci Rep, 7(1), 8975.

Rubsamen N, Akmatov MK, Castell S, Karch A, Mikolajczyk RT. (2017). Comparison of response patterns in different survey designs: a longitudinal panel with mixed-mode and online-only design. Emerg Themes Epidemiol, 14(1), 4.

Rubsamen N, Akmatov MK, Castell S, Karch A, Mikolajczyk RT. (2017). Factors associated with attrition in a longitudinal online study: results from the HaBIDS panel. BMC Med Res Methodol, 17(1), 132.

Schlinkmann KM, Bakuli A, Mikolajczyk R. (2017). Incidence and comparison of retrospective and prospective data on respiratory and gastrointestinal infections in German households. BMC Infectious Diseases, 17(1), 336.

Schlinkmann KM, Glöckner S, Adeoye O, Ameh C, Ihekweazu C, Nguku P, . . . Krause G. (2017). Poster: Surveillance and Outbreak Response Management and Analysis System (SORMAS) - an open source mHealth tool. Paper presented at the 3rd African Conference on Emerging Infectious Disease and Biosecurity, Accra, Ghana.

Schweitzer A, Akmatov MK, Krause G. (2017). Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bulletin of the World Health Organization, 95(3), 199-209G.

Zoch B, Gunther A, Karch A, Mikolajczyk R. (2017). Effect of Disease Definition on Perceived Burden of Acute Respiratory Infections in Children: A Prospective Cohort Study Based on Symptom Diaries. Pediatr Infect Dis J, 36(10), 956-961.



Grylka-Baeschlin S, Petersen A, Karch A, Gross MM. (2016). Labour duration and timing of interventions in women planning vaginal birth after caesarean section. Midwifery, 34, 221-229.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B,Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT. (2016). Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother, 12(7), 1766-1776.

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W. (2016). Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS, 30(7), 1089-1098.

Mehraj J, Witte W, Akmatov MK, Layer F, Werner G, Krause G. (2016). Epidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community. In M Stadler, P Dersch (Eds.), How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives (pp. 55-87). Cham: Springer International Publishing.

Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. (2016). Analysis of Practical Identifiability of a Viral Infection Model. PLoS One, 11(12), e0167568.

Obenauer J, Rübsamen N, Castell S, Hoodgarzadeh M, Klett-Tammen CJ, Mikolajczyk R. (2016). Perceptions of Zika virus risk in Lower Saxony in 2016. Paper presented at the DZIF Annual Meeting. German Center for Infections Reearch (DZIF), Flora, Cologne.

Raupach-Rosin H, Rubsamen N, Szkopek S, Schmalz O, Karch A, Mikolajczyk R, Castell S. (2016). Care for MRSA carriers in the outpatient sector: a survey among MRSA carriers and physicians in two regions in Germany. BMC Infect Dis, 16(1), 184.

Schlinkmann KM, Raupach-Rosin H, Hübner J, Mikolajczyk R. (2016). Infection prevention at preschool age - What is reasonable? [Infektionsprävention im Kindergartenalter -Was ist sinnvoll?]. Tägliche Praxis, 58(1), 7-19.



Damm O, Horn J, Mikolajczyk R, Greiner W, Siedler A, Weidemann F, . . . Ultsch B. (2015). PIN70 - Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany. Value in Health, 18(7), A588.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. (2015). Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health, 15(1), 533.

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. (2015). Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Euro Surveill, 20(49).

Nguyen VK, Binder SC, Boianelli A, Meyer-Hermann M, Hernandez-Vargas EA. (2015). Ebola virus infection modeling and identifiability problems. Front Microbiol, 6, 257.

Rubsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, Zoch B, Krause G, Mikolajczyk RT. (2015). Ebola risk perception in Germany, 2014. Emerg Infect Dis, 21(6), 1012-1018.

Schweitzer A, Akmatov MK, Kindler F, Kemmling Y, Kreienbrock L, Krause G, Pessler F. (2015). The impact of distance and duration of travel on participation rates and participants' satisfaction: results from a pilot study at one study centre in Pretest 2 of the German National Cohort. BMJ Open, 5(8), e007461.

Schweitzer A, Krause G, Pessler F, Akmatov MK. (2015). Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan. BMC Public Health, 15(1), 798.

Tom-Aba D, Olaleye A, Olayinka AT, Nguku P, Waziri N, Adewuyi P, . . . Shuaib F. (2015). Innovative technological approach to ebola virus disease outbreak response in Nigeria using the open data kit and form hub technology. PLoS One, 10(6).

Zoch B, Karch A, Dreesman J, Monazahian M, Baillot A, Mikolajczyk RT. (2015). Feasibility of a birth cohort study dedicated to assessing acute infections using symptom diaries and parental collection of biomaterials. BMC Infectious Diseases, 15(1), 436.



Akmatov MK, Mehraj J, Gatzemeier A, Strömpl J, Witte W, Krause G, Pessler F. (2014). Serial home-based self-collection of anterior nasal swabs to detect Staphylococcus aureus carriage in a randomized population-based study in Germany. Int J Infect Dis, 25, 4-10.

Damm O, Horn J, Schmidt T, Neubauer S, Zeidler J, Mikolajczyk R, . . . Ultsch B. (2014). Epidemiology and Costs of Varicella and Herpes Zoster in Germany. Value Health, 17(7), A670-671.

Hense S, Hillebrand K, Horn J, Mikolajczyk R, Schulze-Rath R, Garbe E. (2014). HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data. Hum Vaccin Immunother, 10(6), 1729-1733.

Mehraj J, Akmatov MK, Strompl J, Gatzemeier A, Layer F, Werner G, Pieper DH, Medina E, Witte W, Pessler F, Krause G. (2014). Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS One, 9(9), e107937.



Horn J, Damm O, Kretzschmar ME, Delere Y, Wichmann O, Kaufmann AM, Garbe E, Kramer A, Greiner W, Mikolajczyk RT. (2013). Estimating the long-term effects of HPV vaccination in Germany. Vaccine, 31(19), 2372-2380.

Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. (2013). Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis, 40(1), 28-31.


Example modules:

  • Good Epidemiological Practice
  • Surveillance and Outbreak Investigations
  • Systematic Reviews and Meta-Analysis
  • Machine Learning
PhD Students
Annabelle Bockey
Annabelle Bockey
PhD Student
HZI Campus
Anne Hallet
Anne Hallet
PhD Student
HZI Campus
Robyn Kettlitz
Robyn Kettlitz
PhD Student
HZI Campus
Martin Lotto
Martin Lotto
PhD Student
HZI Campus
Dörthe Meyerdierks
Dörthe Meyerdierks
PhD Student
HZI Campus
Maren Wieder
Maren Wieder
PhD Student
HZI Campus


Prof Gérard Krause

Coordinators (jointly):
Dr Berit Lange
Dr Carolina Klett-Tammen

Department of Epidemiology
Helmholtz Centre for Infection Research
Inhoffenstraße 7
38124 Braunschweig

PhD Office:
Jennifer Birnschein

Phone: + 49 (0) 531 6181 - 3136